The weak outlook for oil prevails and oil prices are sliding back toward 11 year low. Forecasts that the cold snap in Europe and the United States will be short-lived is adding to the pressure on prices. Crude prices have plunged by two-thirds since mid-2014 as soaring output from the Organization of the Petroleum Exporting Countries, Russia and the United States led to a global surplus of between half a million and 2 million barrels per day.More recently, a slowing demand outlook, especially in Asia but also Europe, has started dragging on prices. The Energy Information Administration is expected to release its data on oil supplies today. KaloBios (KBIO) has filed for Chapter 11 bankruptcy. The filing comes as the drug company, which was led by controversial CEO Martin Shkreli, said it would appeal the NASDAQ's decision to delist its shares. Bridgestone says it will not up its offer for Pep Boys (PBY), leaving investor Carl Icahn as the leading bidder.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.